{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:15:14Z","timestamp":1781129714614,"version":"3.54.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Guidelines recommend Menopausal Hormone Therapy (MHT) as the most effective treatment for menopausal symptoms. However, a local study found that the usage of MHT among menopausal women was low (8.1%), with one of the main reasons being it is not recommended by doctors. Therefore, the objectives of this study are to determine the prevalence of offering MHT in treating symptomatic menopausal women among primary care doctors (PCDs) and its associated factors.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This cross-sectional study involved PCDs from the Federal Territory of Kuala Lumpur, the Federal Territory of Putrajaya and the state of Selangor. All PCDs provided services in government primary care clinics from the three states were invited through the doctor in charge of each clinic. An online survey links was provided for the participants to the self-administered questionnaire. The questionnaire included PCDs\u2019 demographics, their menopause management practices, attitudes towards MHT, perceived barriers in offering MHT, knowledge of related guidelines and received training on menopause management. The outcome variable was offering MHT which defined as either prescription of MHT or referral to hospital for MHT initiation. Multivariate logistic regression analysis was performed to determine the factors associated with offering MHT.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The response rate was 42.9% (559\/1301). Of those who participated in the study, 77.8% of PCDs were female and 89.1% were medical officer. Although 66.9% of the participants reported offering MHT to their patients, the actual prescription rate was low (0.9%). Most PCDs (66%) would refer the patients to hospitals. 87.1% of PCDs (487\/559) reported that MHT was not available in their clinic. In the past 12 months, 83% of PCDs had not received any related training. Female PCDs (AOR:2.5, CI: 1.51\u20134.13, p&lt;0.001), perceiving MHT as preference treatment for menopause symptom (AOR:3.6, CI: 2.13\u20136.19, p &lt; 0.001), having likelihood to recommend MHT to family and friends (AOR:3.0, CI: 1.87\u20134.83, p &lt; 0.001), and receiving training on menopause management (AOR:2.7, CI: 1.30\u20135.56, p = 0.008) were the positive predictor of offering MHT. The negative predictors in offering MHT were no-experience in prescribing MHT (AOR: 0.4, CI: 0.15\u20130.87, p = 0.024) and lack of information regarding MHT for the patient (AOR: 0.4, CI:0.20\u20130.67, p &lt; 0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The study revealed a low rate of MHT prescription among PCDs, with many relying on referrals to hospitals for managing menopausal symptoms. The findings underscore the need for strategies that includes fulfilling professional training gaps, improving MHT availability, and improving information dissemination for patient.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0310994","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:24:12Z","timestamp":1727292252000},"page":"e0310994","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of offering menopause hormone therapy among primary care doctors and its associated factors: A cross-sectional study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0693-2614","authenticated-orcid":true,"given":"Tiong Lim","family":"Low","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3895-530X","authenticated-orcid":true,"given":"Ai Theng","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin Kumar","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohayah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"pone.0310994.ref001","unstructured":"Menopause hubs and services\u2014FAQs\u2014Women [Internet]. [cited 2023 Feb 4]. https:\/\/www.health.nsw.gov.au\/women\/Pages\/hub-faqs.aspx"},{"key":"pone.0310994.ref002","unstructured":"Malaysia Ministry of Health. Borang Saringan Status Kesihatan (BSSK)."},{"key":"pone.0310994.ref003","unstructured":"Ministry of Health Malaysia. CPG\u2014Management of Menopause in Malaysia (Edition 2022)."},{"issue":"2","key":"pone.0310994.ref004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS Recommendations on women\u2019s midlife health and menopause hormone therapy","volume":"19","author":"IMS Writing Group","year":"2016","journal-title":"Climacteric"},{"issue":"6","key":"pone.0310994.ref005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/GME.0000000000001282","article-title":"Menopausal hormone therapy trends before versus after 2002: impact of the Women\u2019s Health Initiative Study Results","volume":"26","author":"SL Crawford","year":"2018","journal-title":"Menopause"},{"issue":"4","key":"pone.0310994.ref006","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/13697137.2014.882305","article-title":"A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI)","volume":"17","author":"JE Bl\u00fcmel","year":"2014","journal-title":"Climacteric"},{"key":"pone.0310994.ref007","article-title":"\u201cDavina effect\u201d smashed the menopause taboo","volume":"10","year":"2022","journal-title":"Mail on Sunday"},{"issue":"6","key":"pone.0310994.ref008","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/13697130903470319","article-title":"Experience of hormone replacement therapy among women of Sarawak, Malaysia","volume":"13","author":"SARS Alwi","year":"2010","journal-title":"Climacteric"},{"issue":"1","key":"pone.0310994.ref009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5122(01)00187-6","article-title":"Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden","volume":"39","author":"ST Nilsen","year":"2001","journal-title":"Maturitas"},{"key":"pone.0310994.ref010","doi-asserted-by":"crossref","first-page":"100206","DOI":"10.1016\/j.chbr.2022.100206","article-title":"Response rates of online surveys in published research: A meta-analysis","volume":"7","author":"MJ Wu","year":"2022","journal-title":"Computers in Human Behavior Reports"},{"issue":"4","key":"pone.0310994.ref011","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/13697137.2017.1304906","article-title":"Knowledge and attitudes of health professionals regarding menopausal hormone therapies","volume":"20","author":"L Yeganeh","year":"2017","journal-title":"Climacteric"},{"key":"pone.0310994.ref012","doi-asserted-by":"crossref","unstructured":"Jr D, Lemeshow S, Sturdivant R. The Multiple Logistic Regression Model. In 2013. p. 35\u201347.","DOI":"10.1002\/9781118548387.ch2"},{"issue":"4","key":"pone.0310994.ref013","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2022.0126","article-title":"Hormone replacement therapy prescribing in menopausal women in the UK: a descriptive study","volume":"6","author":"D Alsugeir","year":"2022","journal-title":"BJGP Open"},{"issue":"2","key":"pone.0310994.ref014","first-page":"6","volume":"72","author":"B Abdullah","year":"2017","journal-title":"Prevalence of menopausal symptoms, its effect on quality of life among Malaysian women and their treatment seeking behaviour"},{"issue":"1","key":"pone.0310994.ref015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.healthpol.2004.10.001","article-title":"Physicians and the prescription of hormone replacement therapy in Spain","volume":"73","author":"MJ Bermejo","year":"2005","journal-title":"Health Policy"},{"issue":"4","key":"pone.0310994.ref016","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02642475","article-title":"Effect of physician gender on the prescription of estrogen replacement therapy","volume":"11","author":"TB Seto","year":"1996","journal-title":"J Gen Intern Med"},{"issue":"1","key":"pone.0310994.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5122(01)00185-2","article-title":"What factors account for hormone replacement therapy prescribing frequency?","volume":"39","author":"KM Newton","year":"2001","journal-title":"Maturitas"},{"key":"pone.0310994.ref018","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.publhealth.25.101802.123134","article-title":"Physician gender and patient-centered communication: a critical review of empirical research","volume":"25","author":"DL Roter","year":"2004","journal-title":"Annu Rev Public Health"},{"issue":"6","key":"pone.0310994.ref019","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/13697137.2020.1775809","article-title":"Attitude and knowledge for menopause management among health professionals in mainland China","volume":"23","author":"L Lin","year":"2020","journal-title":"Climacteric"},{"issue":"11","key":"pone.0310994.ref020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5694\/mja2.51981","article-title":"Advancing menopause care in Australia: barriers and opportunities","volume":"218","author":"SR Davis","year":"2023","journal-title":"Medical Journal of Australia"},{"issue":"6","key":"pone.0310994.ref021","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/13697137.2021.1936486","article-title":"Health-care providers\u2019 views of menopause and its management: a qualitative study","volume":"24","author":"SR Davis","year":"2021","journal-title":"Climacteric"},{"key":"pone.0310994.ref022","unstructured":"Malaysia Ministry of Health. Formulari Ubat KKM."},{"issue":"4","key":"pone.0310994.ref023","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/09513590.2017.1405929","article-title":"Awareness of hormone replacement therapy in medical care personnel in Jiaxing, China: a questionnaire survey","volume":"34","author":"L Gao","year":"2018","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"pone.0310994.ref024","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.mayocp.2018.08.033","article-title":"Menopause Management Knowledge in Postgraduate Family Medicine, Internal Medicine, and Obstetrics and Gynecology Residents: A Cross-Sectional Survey","volume":"94","author":"JM Kling","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"3 Pt 1","key":"pone.0310994.ref025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajog.2005.02.080","article-title":"A national probability survey of American Medical Association gynecologists and primary care physicians concerning menopause","volume":"193","author":"B Singh","year":"2005","journal-title":"American journal of obstetrics and gynecology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:24:24Z","timestamp":1727292264000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0310994"}},"subtitle":[],"editor":[{"given":"Ghanshyam G.","family":"Tejani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0310994","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}